Beneath the Skin: A Review of Current Trends and Future Prospects of Transdermal Drug Delivery Systems

Abstract

The ideal drug delivery system has a bioavailability comparable to parenteral dosage forms but is as convenient and easy to use for the patient as oral solid dosage forms. In recent years, there has been increased interest in transdermal drug delivery (TDD) as a non-invasive delivery approach that is generally regarded as being easy to administer to more vulnerable age groups, such as paediatric and geriatric patients, while avoiding certain bioavailability concerns that arise from oral drug delivery due to poor absorbability and metabolism concerns. However, despite its many merits, TDD remains restricted to a select few drugs. The physiology of the skin poses a barrier against the feasible delivery of many drugs, limiting its applicability to only those drugs that possess physicochemical properties allowing them to be successfully delivered transdermally. Several techniques have been developed to enhance the transdermal permeability of drugs. Both chemical (e.g., thermal and mechanical) and passive (vesicle, nanoparticle, nanoemulsion, solid dispersion, and nanocrystal) techniques have been investigated to enhance the permeability of drug substances across the skin. Furthermore, hybrid approaches combining chemical penetration enhancement technologies with physical technologies are being intensively researched to improve the skin permeation of drug substances. This review aims to summarize recent trends in TDD approaches and discuss the merits and drawbacks of the various chemical, physical, and hybrid approaches currently being investigated for improving drug permeability across the skin.

References 332

1. 1.

   Sahoo D., Bandaru R., Samal S.K., Naik R., Kumar P., Kesharwani P., Dandela R., Kesharwani P., Taurin S., Greish K. Chapter 9—Oral drug delivery of nanomedicine. Theory and Applications of Nonparenteral Nanomedicines. 2021;181-207.

   Not in our library

2. 2.

   He M., Zhu L., Yang N., Li H., Yang Q. Recent advances of oral film as platform for drug delivery. Int. J. Pharm. 2021;604:120759.

   Not in our library10.1016/j.ijpharm.2021.120759

3. 3.

   Kaur G., Arora M., Ravi Kumar M.N.V. Oral Drug Delivery Technologies-A Decade of Developments. J. Pharmacol. Exp. Ther. 2019;370:529-543.

   Not in our library10.1124/jpet.118.255828

4. 4.

   Raza A., Hayat U., Bilal M., Iqbal H.M.N., Wang J.-Y. Zein-based micro- and nano-constructs and biologically therapeutic cues with multi-functionalities for oral drug delivery systems. J. Drug Deliv. Sci. Technol. 2020;58:101818.

   Not in our library10.1016/j.jddst.2020.101818

5. 5.

   Gulati N., Gupta H. Parenteral drug delivery: A review. Recent Pat. Drug Deliv. Formul. 2011;5:133-145.

   Not in our library10.2174/187221111795471391

6. 6.

   Nagarsenkar M.S., Dhawan V.V., Adejare A. Chapter 29—Parenteral preparations. Remington (Twenty-third Edition). 2021;577-603.

   Not in our library

7. 7.

   Pastore M.N., Kalia Y.N., Horstmann M., Roberts M.S. Transdermal patches: History, development and pharmacology. Br. J. Pharmacol. 2015;172:2179-2209.

   Not in our library10.1111/bph.13059

8. 8.

   Prausnitz M.R., Langer R. Transdermal drug delivery. Nat. Biotechnol. 2008;26:1261-1268.

   Not in our library10.1038/nbt.1504

9. 9.

   Sharma G., Alle M., Chakraborty C., Kim J.C. Strategies for transdermal drug delivery against bone disorders: A preclinical and clinical update. J. Control. Release. 2021;336:375-395.

   Not in our library10.1016/j.jconrel.2021.06.035

10. 10.
    Recent advances in transdermal drug delivery systems: a review · 2021

    No notice
11. 11.

    Jung J.H., Jin S.G. Microneedle for transdermal drug delivery: Current trends and fabrication. J. Pharm. Investig. 2021;51:503-517.

    Not in our library10.1007/s40005-021-00512-4

12. 12.

    Khoury R., Rajamanickam J., Grossberg G.T. An update on the safety of current therapies for Alzheimer’s disease: Focus on rivastigmine. Ther. Adv. Drug Saf. 2018;9:171-178.

    Not in our library10.1177/2042098617750555

13. 13.

    Tsuno N., Mori T., Ishikawa I., Bando N., Park H., Matsumoto Y., Mori I., Tanaka M., Hirano T., Nakamura Y. Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer’s disease: The Attitude Towards Food Consumption in Alzheimer’s Disease Patients Revive with Rivastigmine Effects study. Geriatr. Gerontol. Int. 2019;19:571-576.

    Not in our library10.1111/ggi.13644

14. 14.
    Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the Stratum Corneum · 2015

    No notice
15. 15.

    Bajaj S., Whiteman A., Brandner B. Transdermal drug delivery in pain management. Contin. Educ. Anaesth. Crit. Care Pain. 2011;11:39-43.

    Not in our library10.1093/bjaceaccp/mkq054

16. 16.

    Abrams L.S., Skee D.M., Natarajan J., Wong F.A., Anderson G.D. Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites. Br. J. Clin. Pharmacol. 2002;53:141-146.

    Not in our library10.1046/j.0306-5251.2001.01532.x

17. 17.

    Frampton J.E. Rotigotine Transdermal Patch: A Review in Parkinson’s Disease. CNS Drugs. 2019;33:707-718.

    Not in our library10.1007/s40263-019-00646-y

18. 18.

    Schaer D.H., Buff L.A., Katz R.J. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval. Am. J. Cardiol. 1988;61:46-50.

    Not in our library10.1016/0002-9149(88)91302-1

19. 19.

    Vartan C.M. Buprenorphine Transdermal Patch: An Overview for Use in Chronic Pain. US Pharm. 2014;10:16.

    Not in our library

20. 20.

    Tanida N., Akiyama K., Terahara T. [Pharmacological profile and clinical efficacy of transdermal patch containing emedastine difumarate (ALLESAGA(®) TAPE)]. Nihon Yakurigaku Zasshi. Folia Pharmacol. Jpn. 2018;152:246-255.

    Not in our library10.1254/fpj.152.246

21. 21.

    Birks J.S., Grimley Evans J. Rivastigmine for Alzheimer’s disease. Cochrane Database Syst. Rev. 2015;4:Cd001191.

    Not in our library10.1002/14651858.cd001191.pub3

22. 22.

    Westhoff C.L., Reinecke I., Bangerter K., Merz M. Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: A multicenter, open-label, uncontrolled study over three treatment cycles. Contraception. 2014;90:272-279.

    Not in our library10.1016/j.contraception.2014.04.018

23. 23.

    Yousef H., Alhajj M., Sharma S. Anatomy, Skin (Integument), Epidermis. 2022.

    Not in our library

24. 24.

    Kahraman E., Kaykın M., Şahin Bektay H., Güngör S. Recent Advances on Topical Application of Ceramides to Restore Barrier Function of Skin. Cosmetics. 2019;6:52.

    Not in our library10.3390/cosmetics6030052

25. 25.

    Bouwstra J.A., Groenink H.W.W., Kempenaar J.A., Romeijn S.G., Ponec M. Water Distribution and Natural Moisturizer Factor Content in Human Skin Equivalents Are Regulated by Environmental Relative Humidity. J. Investig. Dermatol. 2008;128:378-388.

    Not in our library10.1038/sj.jid.5700994

26. 26.

    Lai-Cheong J.E., McGrath J.A. Structure and function of skin, hair and nails. Medicine. 2021;49:337-342.

    Not in our library10.1016/j.mpmed.2021.03.001

27. 27.

    Al-Akayleh F., Adwan S., Khanfar M., Idkaidek N., Al-Remawi M. A Novel Eutectic-Based Transdermal Delivery System for Risperidone. AAPS PharmSciTech. 2020;22:4.

    Not in our library10.1208/s12249-020-01844-4

28. 28.

    Richard C., Cassel S., Blanzat M. Vesicular systems for dermal and transdermal drug delivery. RSC Adv. 2021;11:442-451.

    Not in our library10.1039/d0ra09561c

29. 29.

    Moronkeji K., Todd S., Dawidowska I., Barrett S.D., Akhtar R. The role of subcutaneous tissue stiffness on microneedle performance in a representative in vitro model of skin. J. Control. Release. 2017;265:102-112.

    Not in our library10.1016/j.jconrel.2016.11.004

30. 30.

    Karande P., Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim. et Biophys. Acta (BBA) Biomembr. 2009;1788:2362-2373.

    Not in our library10.1016/j.bbamem.2009.08.015

31. 31.

    Alkilani A.Z., Alkalbani R., Jaber D., Hamed R., Hamad I., Abumansour H., Assab M.A. Knowledge, attitude, practice and satisfaction of patients using analgesic patches in Jordan. Trop. J. Pharm. Res. 2019;18:1745-1753.

    Not in our library

32. 32.

    Berner B., John V.A. Pharmacokinetic Characterisation of Transdermal Delivery Systems. Clin. Pharmacokinet. 1994;26:121-134.

    Not in our library10.2165/00003088-199426020-00005

33. 33.

    Parhi R., Mandru A. Enhancement of skin permeability with thermal ablation techniques: Concept to commercial products. Drug Deliv. Transl. Res. 2021;11:817-841.

    Not in our library10.1007/s13346-020-00823-3

34. 34.

    Kurz A., Farlow M., Lefèvre G. Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer’s disease: A review. Int. J. Clin. Pract. 2009;63:799-805.

    Not in our library10.1111/j.1742-1241.2009.02052.x

35. 35.

    Lane M.E. Skin penetration enhancers. Int. J. Pharm. 2013;447:12-21.

    Not in our library10.1016/j.ijpharm.2013.02.040

36. 36.

    Hamed R., Al Baraghthi T., Alkilani A.Z., Abu-Huwaij R. Correlation between rheological properties and in vitro drug release from penetration enhancer-loaded Carbopol® gels. J. Pharm. Innov. 2016;11:339-351.

    Not in our library10.1007/s12247-016-9262-9

37. 37.

    Hao Y., Li W., Zhou X., Yang F., Qian Z. Microneedles-based transdermal drug delivery systems: A review. J. Biomed. Nanotechnol. 2017;13:1581-1597.

    Not in our library10.1166/jbn.2017.2474

38. 38.
    Enhancement strategies for transdermal drug delivery systems: current trends and applications · 2021

    No notice
39. 39.

    Akhtar N., Singh V., Yusuf M., Khan R.A. Non-invasive drug delivery technology: Development and current status of transdermal drug delivery devices, techniques and biomedical applications. Biomed. Eng./Biomed. Tech. 2020;65:243-272.

    Not in our library10.1515/bmt-2019-0019

40. 40.

    Subedi R.K., Oh S.Y., Chun M.-K., Choi H.-K. Recent advances in transdermal drug delivery. Arch. Pharmacal Res. 2010;33:339-351.

    Not in our library10.1007/s12272-010-0301-7

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.